Patient-specific heat and field mapping for tumor ablation
This technology is a software-based planning tool for doctors performing tumor ablation using electrical pulses (a technique called irreversible electroporation, or IRE). Before a procedure, the system lets the physician input electrode placement and pulse parameters, then instantly models how heat and electric fields will spread through the target tissue. The result is displayed as a visual map showing the predicted ablation zone, so the doctor can adjust the plan before making a single incision. The goal is to make these minimally invasive cancer treatments more precise and safer by reducing guesswork.
What you could build
A pre-procedural and intra-procedural treatment planning software module integrated with irreversible electroporation (IRE) systems — such as those used to treat pancreatic, liver, or prostate cancer — sold to hospitals and interventional oncology centers as either a standalone software license or bundled with ablation hardware.
Who in Virginia should care
Interventional oncology programs at major Virginia health systems (Inova, VCU Health, UVA Health) and medtech device companies in the Northern Virginia/DC corridor would be natural early adopters or licensing partners.
Readiness: Prototype likely
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- Paulo A. Garcia, Christopher B. Arena, Michael B. Sano, Rafael V. Davalos
- Filed
- Patent pending — filed August 18, 2025
- Status
- Application
- Publication number
- US20260033889A1
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.